Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J. Hsieh, Robert J. Motzer, Almedina Redzematovic et al.|European Urology|2016Cited by 204
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell CarcinomaMartin H. Voss, Darren R. Feldman, Ana M. Molina et al.|Journal of Clinical Oncology|2016Cited by 85